The Department of Molecular Biology and Biotechnology, University of Cape Coast (UCC), is proud to celebrate the remarkable achievement of its former student, Mr. Kwadwo Fosu, who is currently pursuing a PhD in Translational Cancer Biology at Indiana University School of Medicine, Indianapolis, USA.

Mr. Fosu has been recognized as a co-author of a groundbreaking study published by researchers at the Indiana University School of Medicine. The study reports the development of an innovative nanoparticle-based delivery system capable of directing cancer therapies specifically to multiple myeloma cells while minimizing damage to healthy tissues. The research represents a significant advancement in the quest for safer and more effective treatments for blood cancers. 

According to the Indiana University School of Medicine, the research team successfully engineered lipid nanoparticles that can be redirected from their normal destination in the liver to the bone marrow by attaching antibodies that recognize BCMA, a marker found on multiple myeloma cells. This targeted approach has demonstrated promising results in preclinical studies and could pave the way for more precise cancer therapies in the future. 

Kwadwo Fosu is an alumnus of the Department of Molecular Biology and Biotechnology, UCC, where he pursued his undergraduate studies between 2015 and 2019. Following his graduation, he served as a Teaching Assistant during the 2019/2020 academic year under the supervision of Professor Foster Kyei, contributing to teaching, laboratory instruction, and student mentorship within the department.

Since leaving UCC, Mr. Fosu has continued to distinguish himself through research excellence. He is currently a PhD student at Indiana University, where his research interests focus on cancer biology and translational biomedical research. 

The Department extends its heartfelt congratulations to Mr. Fosu on this significant accomplishment. His contribution to internationally recognized cancer research serves as an inspiration to current students and demonstrates the global impact that graduates of the Department of Molecular Biology and Biotechnology can make through dedication, innovation, and scientific excellence.

The Department wishes him continued success in his doctoral studies and future research endeavors as he contributes to advancing knowledge and improving human health worldwide. 

For reference, the Indiana University School of Medicine news release can be found at: [Indiana University School of Medicine News Release]https://medicine.iu.edu/news/2026/06/nanoparticle-blood-cancer-target?utm_source=chatgpt.com